KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Inventory: 2012-2024

Historic Change in Inventory for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Dec 2024 value amounting to -$15.8 million.

  • Supernus Pharmaceuticals' Change in Inventory rose 381.06% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135,000, marking a year-over-year increase of 100.77%. This contributed to the annual value of -$15.8 million for FY2024, which is 158.69% down from last year.
  • According to the latest figures from FY2024, Supernus Pharmaceuticals' Change in Inventory is -$15.8 million, which was down 158.69% from -$6.1 million recorded in FY2023.
  • Over the past 5 years, Supernus Pharmaceuticals' Change in Inventory peaked at $17.9 million during FY2022, and registered a low of -$15.8 million during FY2024.
  • For the 3-year period, Supernus Pharmaceuticals' Change in Inventory averaged around -$1.4 million, with its median value being -$6.1 million (2023).
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 944.79% in 2020, then crashed by 158.69% in 2024.
  • Supernus Pharmaceuticals' Change in Inventory (Yearly) stood at $10.1 million in 2020, then skyrocketed by 44.01% to $14.6 million in 2021, then rose by 22.48% to $17.9 million in 2022, then tumbled by 134.21% to -$6.1 million in 2023, then tumbled by 158.69% to -$15.8 million in 2024.